Delivery Order SPE2DB20D1100-SPE2DB25FD8Y8
- Not listed
- The Defense Logistics Agency awarded a $7,255.25 delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 ml pen injections on August 28, 2025, with completion targeted for September 19, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. The contract, valued at $7,255.25, carries a firm fixed price and is scheduled for completion by October 8, 2025. This competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under...
- The Defense Logistics Agency awarded a $7,255.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of TREMFYA 200 mg/2 ml pen injections. This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a $7,255.25 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by July 30, 2025. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of TREMFYA 200 mg/2 mL pens valued at $21,765.75 under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 5, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $14,510.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for TREMFYA 200 mg/2 mL pen injections. This is a non-set-aside competitive award with a completion date of September 4, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order valued at $42,826.81 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's Conshohocken, Pennsylvania location. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $21,765.75 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL pharmaceutical product on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $19,006 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical products on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive award is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8Y8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen injections on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that functions as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies to support Defense Health Agency and other government healthcare systems. This delivery order for TREMFYA, a specialty pharmaceutical product, reflects the company's ongoing role in fulfilling military medical supply requirements through the DLA's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/6/25 |